Medicare Enrolled

Dr. Mehak Chopra, NP

Hematology & Oncology · Palo Alto, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
195 PAGE MILL RD STE 103, Palo Alto, CA 94306
8887318984
In practice since 2020 (5 years)
NPI: 1447854633 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chopra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chopra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chopra

Dr. Mehak Chopra is a hematology & oncology specialist in Palo Alto, CA, with 5 years of NPI registration. Based on federal Medicare data, Dr. Chopra performed 902 Medicare services across 529 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chopra received a total of $7,884 from 72 pharmaceutical and/or device companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chopra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years in practice ▲ 902 Medicare services $7,884 industry payments

Medicare Practice Summary

Medicare Utilization ↗
902
Medicare services
Bottom 48% in CA for hematology & oncology
529
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~180 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
300 $74 $210
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
214 $132 $320
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
193 $52 $160
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
108 $69 $221
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $48 $151
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
32 $60 $296
Nursing facility visit, high complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes.
12 $106 $320
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,884
Total received (2021-2024)
Avg $1,971/year across 4 years
Top 36% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
368
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,474 (94.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$410 (5.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$172
2023
$302
2022
$2,861
2021
$4,550

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$49
Verity Pharmaceuticals Inc.
$29
Celgene Corporation
$28
Novartis Pharmaceuticals Corporation
$24
RECORDATI_RARE_DISEASES_INC.
$24
Daiichi Sankyo Inc.
$19
Top 3 companies account for 61.5% of 2024 payments
All-time payments by company (2021-2024) ›
Amgen Inc.
$651
Janssen Biotech, Inc.
$592
E.R. Squibb & Sons, L.L.C.
$399
Seagen Inc.
$333
AstraZeneca Pharmaceuticals LP
$322
NOVARTIS PHARMACEUTICALS CORPORATION
$289
Celgene Corporation
$274
Incyte Corporation
$270
Lilly USA, LLC
$241
Merck Sharp & Dohme Corporation
$234
Daiichi Sankyo Inc.
$233
Astellas Pharma US Inc
$226
Novartis Pharmaceuticals Corporation
$224
GENZYME CORPORATION
$195
Pharmacyclics LLC, an AbbVie Company
$189
Rigel Pharmaceuticals, Inc.
$182
Takeda Pharmaceuticals U.S.A., Inc.
$168
Karyopharm Therapeutics Inc.
$155
PUMA BIOTECHNOLOGY, INC.
$153
GlaxoSmithKline, LLC.
$150
Alexion Pharmaceuticals, Inc.
$146
Merck Sharp & Dohme LLC
$144
PFIZER INC.
$131
BeiGene USA, Inc.
$128
Gilead Sciences, Inc.
$116
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
SANOFI-AVENTIS U.S. LLC
$100
EMD Serono, Inc.
$96
Deciphera Pharmaceuticals Inc.
$81
Bayer HealthCare Pharmaceuticals Inc.
$70
ABBVIE INC.
$68
MorphoSys, US Inc.
$64
Global Blood Therapeutics, Inc.
$60
Myovant Sciences Inc.
$57
Octapharma USA, Inc.
$51
Genentech USA, Inc.
$49
Dova Pharmaceuticals
$49
Exelixis Inc.
$48
Sobi, Inc
$47
AbbVie Inc.
$44
Ipsen Biopharmaceuticals, Inc
$44
EISAI INC.
$43
EUSA Pharma (US) LLC
$43
TerSera Therapeutics LLC
$42
Foundation Medicine, Inc.
$33
AVEO Pharmaceuticals, Inc.
$29
Verity Pharmaceuticals Inc.
$29
Blueprint Medicines Corporation
$28
Novocure Inc.
$27
Regeneron Healthcare Solutions, Inc.
$26
Aveo Pharmaceuticals, Inc.
$24
GE HealthCare
$24
AMAG Pharmaceuticals, Inc.
$24
G1 Therapeutics, Inc.
$24
Kyowa Kirin, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$24
Pharmacyclics LLC, An AbbVie Company
$23
PharmaEssentia USA Corporation
$22
Coherus Biosciences Inc.
$22
ADC Therapeutics America, Inc.
$21
Taiho Oncology, Inc.
$19
Kite Pharma, Inc.
$18
Acrotech Biopharma LLC
$17
ACCORD HEALTHCARE, INC.
$17
Servier Pharmaceuticals LLC
$16
Alnylam Pharmaceuticals Inc.
$15
Myriad Genetic Laboratories, Inc.
$15
Agios Pharmaceuticals, Inc.
$15
JAZZ PHARMACEUTICALS INC.
$13
Emmaus Medical, Inc.
$12
GE HEALTHCARE
$11
Janssen Pharmaceuticals, Inc
$7
Top 3 companies account for 20.8% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALUNBRIG · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Endari · Enhertu · FERAHEME · FOTIVDA · FOUNDATIONONE · GAMIFANT · GAVRETO · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · Lenvima · MEKINIST · MONJUVI · NERLYNX · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Optune · PADCEV · PANZYGA · PLUVICTO · POTELIGEO · PROMACTA · Pomalyst · QINLOCK · REBLOZYL · Revlimid · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SYLVANT · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trelstar · Trodelvy · Turalio · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · XALKORI · XARELTO · XPOVIO · XTANDI · XYNTHA · Xermelo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Palo Alto?
Compare hematology & oncology specialists in the Palo Alto area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
125
Per 100K population
6.6
County median income
$159,674
Nearest hospital
STANFORD HEALTH CARE
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chopra is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chopra experienced with nursing facility visit, moderate complexity?
Based on Medicare claims data, Dr. Chopra performed 300 nursing facility visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chopra receive payments from pharmaceutical companies?
Yes. Dr. Chopra received a total of $7,884 from 72 companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chopra's costs compare to other hematology & oncology specialists in Palo Alto?
Dr. Chopra's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chopra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →